World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
28060
World Ranking
19546
National Ranking
54

Overview

Angelos Hatzakis is affiliated with the National and Kapodistrian University of Athens in Greece. Their research primarily spans the field of Medicine, with a focus on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, General Health Professions, and Virology.

The scientist's work has a strong emphasis on topics related to HIV, drug use, and sexual risk, as well as research and interventions addressing HIV/AIDS. Additionally, they contribute to the understanding of SARS-CoV-2 and COVID-19, including clinical research studies surrounding these viruses. Other areas of focus include hepatitis C virus research and opioid use disorder treatment.

Recent scholarly papers authored or co-authored by Angelos Hatzakis include:

  • Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2, 2021, Vaccines
  • Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients, 2021, American Journal of Transplantation
  • HIV outbreaks among people who inject drugs in Europe, North America, and Israel, 2020, The Lancet HIV
  • Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19, 2020, PLoS ONE
  • The case for simplifying and using absolute targets for viral hepatitis elimination goals, 2020, Journal of Viral Hepatitis

Angelos Hatzakis has frequently published in several venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccines
  • AIDS and Behavior
  • Journal of Hepatology
  • International Journal of Drug Policy

Frequent co-authors with whom they have collaborated extensively are:

  • Vana Sypsa
  • Dimitrios Paraskevis
  • Sotirios Roussos
  • Mina Psichοgiou
  • George Kalamitsis

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • A proposed system for the nomenclature of hepatitis C viral genotypes

    P Simmonds;A Alberti;H J Alter;F Bonino

  • Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

    G. R. Simpson;T. F. Schulz;D. Whitby;P. M. Cook

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel

  • Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

    Thomas R. O'Brien;William A. Blattner;David Waters;M. Elaine Eyster

  • Heterosexual Co-transmission of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)

    Eyster Me;Alter Hj;Aledort Lm;Quan S

  • Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma

    Chris Boschoff;Chris Boschoff;Denise Whitby;Denise Whitby;Theodora Hatziionnou;Theodora Hatziionnou;Cyril Fisher;Cyril Fisher

  • Management of antiviral resistance in patients with chronic hepatitis B.

    Stephen Locarnini;Angelas Hatzakis;Jenny Heathcote;Emmet B. Keeffe

  • The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

    A. Hatzakis;S. Wait;J. Bruix;M. Buti

  • Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

    Jean–Michel Pawlotsky;Jean–Michel Pawlotsky;Geoffrey Dusheiko;Angelos Hatzakis;Daryl Lau

  • Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs

    Stephen Locarnini;Angelos Hatzakis;Ding Shinn Chen;Anna Lok

  • Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

    Homie Razavi;Sarah Robbins;Stefan Zeuzem;Francesco Negro

  • Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.

    Andrew N. Phillips;Andrew Carr;Jacquie Neuhaus;Fehmida Visnegarwala

  • Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV-Infected Individuals: A Cohort Study and Meta-Analysis

    Georgios K Nikolopoulos;Dimitrios Paraskevis;Eleni Hatzitheodorou;Zissis Moschidis

  • Care of patients with hepatitis C and HIV co-infection.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Stefan Mauss

  • The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis

    Gkikas Magiorkinis;Emmanouil Magiorkinis;Dimitrios Paraskevis;Simon Y. W. Ho

  • Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.

    E. Kaklamani;D. Trichopoulos;A. Tzonou;X. Zavitsanos

Frequent Co-Authors

Dimitrios Paraskevis
Dimitrios Paraskevis National and Kapodistrian University of Athens
George V. Papatheodoridis
George V. Papatheodoridis National and Kapodistrian University of Athens
Samuel R. Friedman
Samuel R. Friedman National Development and Research Institutes
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Andrzej Horban
Andrzej Horban Medical University of Warsaw
Sabine Yerly
Sabine Yerly University of Geneva
Kristel Van Laethem
Kristel Van Laethem Rega Institute for Medical Research
Dimitrios Trichopoulos
Dimitrios Trichopoulos Harvard University
Mika Salminen
Mika Salminen Finnish Institute for Health and Welfare
Maurizio Zazzi
Maurizio Zazzi University of Siena

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to a traditional MD can open up flexible and rewarding career options in the healthcare field. Many universities now offer online programs for those seeking to advance without stepping away from their current roles. For those interested in healthcare leadership, consider the top cahme-accredited mha programs, which equip graduates with key management and administrative skills.

Registered Nurses looking for advancement might explore the rn to bsn online with no clinicals options, making it easier to earn a bachelor’s degree while balancing work and personal commitments. For those pursuing the highest levels of nursing practice, there are avenues to accelerate progress, such as the shortest msn to dnp program.

Additionally, for professionals who wish to complete advanced degrees with minimal in-person requirements, a variety of online dnp programs without clinicals are available. These online pathways help to break down barriers and broaden access for aspiring leaders in medicine and healthcare.

Best Scientists Citing Angelos Hatzakis

Trending Scientists

Recently Published Articles